Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Pacher

Showing results (11-20 of 89) with videos related to

Pageof 9
Sort By:
European Journal of Heart Failure|August 9, 2005
Short-term effects of levosimendan and prostaglandin E1 on hemodynamic parameters and B-type natriuretic peptide levels in patients with decompensated chronic heart failureDeddo Moertl, Rudolf Berger, Martin Huelsmann, et al.
European Journal of Heart Failure|March 25, 2008
Prognostic value of sequential measurements of amino-terminal prohormone of B-type natriuretic peptide in ambulatory heart failure patientsDeddo Moertl, Alexandra Hammer, Martin Huelsmann, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|January 22, 2004
Neurohumoral and hemodynamic effects of the selective endothelin antagonist darusentan in advanced chronic heart failureJutta Bergler-Klein, Richard Pacher, Rudolf Berger, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 8, 2006
B-type natriuretic peptide and amino terminal proBNP predict one-year mortality in short of breath patients independently of the baseline diagnosis of acute destabilized heart failureAlfons Gegenhuber, Thomas Mueller, Benjamin Dieplinger, et al.
Journal of Cardiac Failure|March 31, 2009
B-type natriuretic peptide predicts benefit from a home-based nurse care in chronic heart failureDeddo Moertl, Rudolf Berger, Alexandra Hammer, et al.
Clinical Chemistry|April 1, 2008
Increased plasma concentrations of soluble ST2 are predictive for 1-year mortality in patients with acute destabilized heart failureThomas Mueller, Benjamin Dieplinger, Alfons Gegenhuber, et al.
European Journal of Heart Failure|June 1, 2005
Incidence of normal values of natriuretic peptides in patients with chronic heart failure and impact on survival: a direct comparison of N-terminal atrial natriuretic peptide, N-terminal brain natriuretic peptide and brain natriuretic peptideMartin Hülsmann, Rudolf Berger, Deddo Mörtl, et al.
Circulation|May 22, 2002
B-type natriuretic peptide predicts sudden death in patients with chronic heart failureRudolf Berger, Martin Huelsman, Karin Strecker, et al.
European Journal of Heart Failure|July 25, 2006
Levosimendan and prostaglandin E1 for uptitration of beta-blockade in patients with refractory, advanced chronic heart failureRudolf Berger, Deddo Moertl, Martin Huelsmann, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 21, 2005
Comparison of soluble glycoprotein 130 and cardiac natriuretic peptides as long-term predictors of heart failure progressionMarianne Gwechenberger, Richard Pacher, Rudolf Berger, et al.
Pageof 9

Showing results (11-20 of 89) with videos related to

Sort By:
Pageof 9
European Journal of Heart Failure|August 9, 2005
Short-term effects of levosimendan and prostaglandin E1 on hemodynamic parameters and B-type natriuretic peptide levels in patients with decompensated chronic heart failureDeddo Moertl, Rudolf Berger, Martin Huelsmann, et al.
European Journal of Heart Failure|March 25, 2008
Prognostic value of sequential measurements of amino-terminal prohormone of B-type natriuretic peptide in ambulatory heart failure patientsDeddo Moertl, Alexandra Hammer, Martin Huelsmann, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|January 22, 2004
Neurohumoral and hemodynamic effects of the selective endothelin antagonist darusentan in advanced chronic heart failureJutta Bergler-Klein, Richard Pacher, Rudolf Berger, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 8, 2006
B-type natriuretic peptide and amino terminal proBNP predict one-year mortality in short of breath patients independently of the baseline diagnosis of acute destabilized heart failureAlfons Gegenhuber, Thomas Mueller, Benjamin Dieplinger, et al.
Journal of Cardiac Failure|March 31, 2009
B-type natriuretic peptide predicts benefit from a home-based nurse care in chronic heart failureDeddo Moertl, Rudolf Berger, Alexandra Hammer, et al.
Clinical Chemistry|April 1, 2008
Increased plasma concentrations of soluble ST2 are predictive for 1-year mortality in patients with acute destabilized heart failureThomas Mueller, Benjamin Dieplinger, Alfons Gegenhuber, et al.
European Journal of Heart Failure|June 1, 2005
Incidence of normal values of natriuretic peptides in patients with chronic heart failure and impact on survival: a direct comparison of N-terminal atrial natriuretic peptide, N-terminal brain natriuretic peptide and brain natriuretic peptideMartin Hülsmann, Rudolf Berger, Deddo Mörtl, et al.
Circulation|May 22, 2002
B-type natriuretic peptide predicts sudden death in patients with chronic heart failureRudolf Berger, Martin Huelsman, Karin Strecker, et al.
European Journal of Heart Failure|July 25, 2006
Levosimendan and prostaglandin E1 for uptitration of beta-blockade in patients with refractory, advanced chronic heart failureRudolf Berger, Deddo Moertl, Martin Huelsmann, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 21, 2005
Comparison of soluble glycoprotein 130 and cardiac natriuretic peptides as long-term predictors of heart failure progressionMarianne Gwechenberger, Richard Pacher, Rudolf Berger, et al.
Pageof 9